President's address. Cancer and the ovary.
D000951:Antigens, Neoplasm; D000963:Antimetabolites / Q000627:therapeutic use; D001201:Ascites / Q000209:etiology; D002369:Castration; D005260:Female; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D006931:Hyperbaric Oxygenation; D000860:Hypoxia / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D009362:Neoplasm Metastasis; D009502:Neutrons; D009858:Oncogenic Viruses; D010048:Ovarian Cysts / Q000150:complications / Q000266:history / Q000601:surgery*; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000266:history* / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy; D010879:Piperazines / Q000627:therapeutic use; D011407:Propane / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D012421:Rupture
D000951:Antigens, Neoplasm; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D010879:Piperazines; D011838:Radiation-Sensitizing Agents; D011407:Propane